AMGN

Amgen Inc.

319.30 USD
+1.15 (+0.36%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Amgen Inc. stock is up 6.37% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 51.22% of the previous 41 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
25 Jun 16:22 17 Jan, 2025 350.00 CALL 21 715
25 Jun 16:22 17 Jan, 2025 350.00 CALL 16 715
25 Jun 16:24 17 Jan, 2025 350.00 CALL 18 715
25 Jun 16:29 26 Jul, 2024 330.00 PUT 50 0
25 Jun 16:36 16 Aug, 2024 335.00 CALL 59 39
25 Jun 16:44 20 Dec, 2024 350.00 CALL 23 63
25 Jun 16:44 20 Dec, 2024 350.00 CALL 27 63
25 Jun 17:10 16 Aug, 2024 350.00 CALL 301 1391
25 Jun 17:14 20 Dec, 2024 350.00 CALL 20 63
25 Jun 17:45 19 Jul, 2024 305.00 PUT 306 1538

About Amgen Inc.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. Its products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis. Repatha reduces the risks of myocardial infarction, stroke, and coronary revascularization.